NextGen Healthcare - NXGN Stock Forecast, Price & News

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.

NextGen Healthcare Trading Down 0.1 %

NXGN traded down $0.01 during trading on Friday, reaching $17.29. 247,880 shares of the company were exchanged, compared to its average volume of 418,950. NextGen Healthcare has a 52 week low of $13.64 and a 52 week high of $21.87. The firm has a 50 day moving average of $17.50 and a 200 day moving average of $18.87. The stock has a market cap of $1.18 billion, a P/E ratio of 1,730.73 and a beta of 1.07.

NextGen Healthcare (NASDAQ:NXGN - Get Rating) last released its quarterly earnings results on Tuesday, May 17th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The business had revenue of $151.26 million during the quarter, compared to analyst estimates of $150.07 million. NextGen Healthcare had a negative net margin of 0.01% and a positive return on equity of 8.20%. The company's quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.13 earnings per share. As a group, analysts forecast that NextGen Healthcare will post 0.62 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Guggenheim raised shares of NextGen Healthcare from a "neutral" rating to a "buy" rating and set a $26.00 price objective for the company in a report on Friday, May 6th.

Insiders Place Their Bets

In other news, Director Craig A. Barbarosh sold 3,500 shares of the stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $18.17, for a total value of $63,595.00. Following the completion of the transaction, the director now directly owns 67,683 shares in the company, valued at $1,229,800.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last quarter, insiders sold 10,500 shares of company stock worth $185,185. 4.50% of the stock is owned by company insiders.